Class IOngoingD-0464-2025
Drug recall · June 18, 2025
MALEXTRA recall
Why: Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
MALEXTRA, Recharge with Extra, Dietary Supplement, 10 capsules per box, Distributed by: Health Fixer, Tempe, AZ 85288, UPC B0CWKZ6ZP3.
- Lots / codes
All lots Lot #: KT-1ST-43-01-04/2026, Exp. 04/25/2026
- Quantity
- 500 boxes
- Company
- Saini Trade Inc, Tempe, AZ
- Distribution
- Nationwide
- Initiated
- April 14, 2025 · Voluntary: Firm initiated
- Classified
- June 11, 2025
- Reported
- June 18, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.